Current status and perspective of antiangiogenic therapy for cancer: hepatocellular carcinoma.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

16 citing papers in PubMed, 36 citations in OpenAlex.

1. Application of laparoscopic intraoperative ultrasound in laparoscopic hepatic resection for liver tumor.World journal of gastrointestinal surgery · 2025
   Review
2. Exosome-derived SNHG16 sponging miR-4500 activates HUVEC angiogenesis by targeting GALNT1 via PI3K/Akt/mTOR pathway in hepatocellular carcinoma.Journal of physiology and biochemistry · 2021
   Article
3. Fumagillin, a Mycotoxin ofToxins · 2019
   Review
4. Evaluation of Contrast-Enhanced Intraoperative Ultrasound in the Detection and Management of Liver Lesions in Patients with Hepatocellular Carcinoma.Journal of oncology · 2019
   Article
5. Long non-coding RNA UBE2CP3 enhances HCC cell secretion of VEGFA and promotes angiogenesis by activating ERK1/2/HIF-1α/VEGFA signalling in hepatocellular carcinoma.Journal of experimental & clinical cancer research : CR · 2018
   Article
6. Co-expression Network Analysis Identified COL8A1 Is Associated with the Progression and Prognosis in Human Colon Adenocarcinoma.Digestive diseases and sciences · 2018
   Article
7. Identification of Potential Key Genes Associated With the Pathogenesis and Prognosis of Gastric Cancer Based on Integrated Bioinformatics Analysis.Frontiers in genetics · 2018
   Article
8. Novel Aurora/vascular endothelial growth factor receptor dual kinase inhibitor as treatment for hepatocellular carcinoma.Cancer science · 2015
   Article
9. Contrast-enhanced ultrasound: Improving the preoperative staging of hepatocellular carcinoma and guiding individual treatment.World journal of gastroenterology · 2014
   Article
10. Hypoxia effects on proangiogenic factors in human umbilical vein endothelial cells: functional role of the peptide somatostatin.Naunyn-Schmiedeberg's archives of pharmacology · 2011
    Article
11. Molecular targeted therapy for hepatocellular carcinoma in the current and potential next strategies.Journal of gastroenterology · 2011
    Review
12. Current status of molecularly targeted therapy for hepatocellular carcinoma: basic science.International journal of clinical oncology · 2010
    Review
13. Endocan expression correlated with poor survival in human hepatocellular carcinoma.Digestive diseases and sciences · 2009
    Article
14. Molecularly targeted therapy for hepatocellular carcinoma.Cancer science · 2009
    Review
15. Suppression of tumor growth and angiogenesis by a specific antagonist of the cell-surface expressed nucleolin.PloS one · 2008
    Article
16. Imagiological Diagnosis of Gastrointestinal Diseases - Diagnostic Criteria of Hepatocellular Carcinoma.GE Portuguese journal of gastroenterology
    Review

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

Authors and funding

2 authors at 1 institution in 1 country.

Funding

No grant is acknowledged in the PubMed record.

Abstract

Indexed as